For patients at high risk for fracture due to osteoporosis
FORTEO (teriparatide injection) can help reduce your risk of having another fracture*
FORTEO is a prescription medication used in both men and postmenopausal women with osteoporosis who are at high risk for having broken bones, or fractures. FORTEO is used in both men and women with osteoporosis due to use of glucocorticoid medicines, such as prednisone, for several months, who are at high risk for having broken bones, or fractures. FORTEO can be used by people who have had a fracture related to osteoporosis, or who have several risk factors for fracture, or who cannot use other osteoporosis treatments.
*Only proven in postmenopausal women with osteoporosis. All women took calcium and vitamin D daily.
Lower your monthly cost to as little as $4 with the FORTEO co-pay card†
Governmental beneficiaries excluded, terms and conditions apply.
†Offer good until 12/31/2021. Patients must have coverage for FORTEO through their commercial drug insurance to pay as little as $4 for a 28-day supply of FORTEO. Offer subject to a monthly cap of wholesale acquisition cost plus usual and customary pharmacy charges and a separate $9,000 maximum annual cap. Patient cannot use the card past 24 months of therapy. Patient is responsible for any applicable taxes, fees, or amounts exceeding monthly or annual caps. This offer is invalid for patients without commercial drug insurance or whose prescription claims for FORTEO are eligible to be reimbursed, in whole or in part, by any governmental program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medigap, DoD, VA, TRICARE®/CHAMPUS, or any state patient or pharmaceutical assistance program. Offer void where prohibited by law and subject to change or discontinue without notice. Card activation is required. Subject to additional terms and conditions, which can be found here.
Start managing your osteoporosis with FORTEO
Consult your healthcare provider to determine if FORTEO is right for you.
ǂFDA approval in 2002
§Cumulative worldwide exposure through 31 August 2017 across all approved indications.
FORTEO Connect™ is available for free support
Joining FORTEO Connect™ provides access to a team of professionals committed to helping you get off to a good start. FREE support includes:
- FORTEO information and injection training
- Insurance investigation